Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC.
Anne SchettSacha I RothschildAlessandra Curioni-FontecedroStephan KrähenbühlMartin FrühS SchmidChristoph DriessenMarkus JoergerPublished in: Cancer chemotherapy and pharmacology (2019)
The results of this study suggest that ATB may have a deleterious effect in patients with advanced NSCLC receiving ICI treatment, and more research seems to be justified to explore potential mechanisms.